Pfizer CEO Dr. Albert Bourla says Covid-19 vaccine has over 90 percent success rate.
- Posted on November 09, 2020
- Editors Pick
- By admin
Pfizer CEO Dr. Albert Bourla appeared on CNBC today to report that they have found the solution to the Coronavirus pandemic and that their Coronavirus vaccine study has over 90 % success rate. This means that we may finally return back to normal if the vaccine is indeed helpful in helping to cure the deadly disease that has claimed thousands of lives worldwide.
“I think we can see light at the end of the tunnel,” Pfizer Chairman and CEO Dr. Albert Bourla told CNBC’s Meg Tirell on “Squawk Box.” “I believe this is likely the most significant medical advance in the last 100 years, if you count the impact this will have in public health, global economy.
“The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” Bourla said in a statement.
“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen,” Bourla continued.
“With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis. We look forward to sharing additional efficacy and safety data generated from thousands of participants in the coming weeks.”
The stay at home stocks is getting crushed today when Pfizer broke the news that they have attained over 90 % success rate with their covid-19 vaccines study. Pfizer stock is up by over 9% at the time of this report.
Technology stocks like Amazon and Netflix dropped 1.6% and 4.7%, respectively. Teladoc Health slid 7.4% and Shopify declined by 5.5%.
Zoom is also down by 14% as people are rushing to sell these stocks
and they are likely buying the stocks that are affected by Covid.
Be the first to comment!
You must login to comment